Note: Ingredients listed on restricted chemical lists
EC/CAS
238-878-4/14808-60-7
Name of the chemical
Silica, crystalline
Concentration
<90
General Information
Version
10.0 Date
Revision date
2023-02-03
Product name
ISG DORSIMIX QM
Product name
ISG DORSIMIX QM
Identification on the label/Trade name
non exhaustive list: DORSIMIX associated to different type designations
CAS No.
14808-60-7
REACH No
exempted
supplier name
ISG Industriegesellschaft mbH
Emergency telephone
+49 9622 82-0, +49 9622 82-206, +44 (171) 635 91 91, +353 1 809 2566, +356 2122 4071
Icons in SDS
Company Information
company name
ISG Industriegesellschaft mbH
GHS Information
Signal word
DANGER
Hazard Codes
Hazard statements (CLP)
H372
Hazard statements
Code
Statements
H372
Causes damage to organs through prolonged or repeated exposure
Section 2
SECTION 2: Hazards identification
Classification according to Regulation (EC) No. 1272/2008 [CLP Classification of the substance or mixture
Signal word
DANGER
Hazard statements
H372: May cause damage to the lung through prolonged or repeated exposure by inhalation.
Precautionary statements
P260: Do not breathe dust. P264: Wash hands thoroughly after handling. P270: Do not eat, drink or smoke when using this product. P284: [In case of inadequate ventilation] wear respiratory protection (at least FFP2-type protective filtering masks). P314: Get medical advice / attention if you feel unwell. P501: Dispose of contents/container in accordance with local regulations.
2.3 Other hazards
This product is an inorganic mixture and fails to meet the criteria set out in Annex XIII of the REACH Regulation for the identification of PBT substances and vPvB. Quartz has no endocrine disrupting properties as defined in Commission Delegated Regulation (EU) 2017/2100 or set out in Commission Regulation (EU) 2018/605. Depending on the type of handling and use, airborne respirable crystalline silica may be generated. Prolonged/extensive exposure to respirable crystalline silica dusts can potentially cause silicosis, a long-term lung disease.
2.1 Classification of the substance or mixture
substance or mixture Classification according to STOT RE 1, H372 Regulation (EC) No 1278/2008 (CLP)
